FinscoFinsco

Chemed (US.CHE)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CHE · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion81.1%→
ROE16.1%↑
Cash Conversion129.1%↓
D/E Ratio0.35↓
Gross Margin32.9%→
US.CHE (Chemed) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion    81.1%    →
ROE               16.1%    ↑
Cash Conversion  129.1%    ↓
D/E Ratio          0.35    ↓
Gross Margin      32.9%    →
Key Metrics
US.CHE (Chemed) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 81.1% →
ROE 16.1% ↑
Cash Conversion 129.1% ↓
D/E Ratio 0.35 ↓
Gross Margin 32.9% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies